Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 14351-14400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06621238
The Effect of Musıc on Labor Paın, Anxıety and Breastfeedıng Success
NARecruiting
140 participants
Started: Dec 7, 2024 · Completed: Apr 15, 2025
4 conditions1 sponsor1 location
NCT04679844
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
NARecruiting
60 participants
Started: Dec 6, 2024 · Completed: Aug 30, 2027
3 conditions3 sponsors4 locations
NCT06767488
Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors
N/ARecruiting
375 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT06510491
Epcoritamab in Previously Treated WM
PHASE2Recruiting
20 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors3 locations
NCT06553235
RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention
NARecruiting
84 participants
Started: Dec 6, 2024 · Completed: Mar 28, 2030
3 conditions2 sponsors1 location
NCT06528171
Covid-19 Long Immunité IMagerie (CLIIM)
NARecruiting
200 participants
Started: Dec 6, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06706674
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
PHASE3Recruiting
174 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor39 locations
NCT06540963
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
PHASE2Recruiting
98 participants
Started: Dec 6, 2024 · Completed: Dec 1, 2035
1 condition1 sponsor3 locations
NCT06614491
SCOPE - Single-Point Classification Observational Peristomal Evaluation
N/ARecruiting
600 participants
Started: Dec 6, 2024 · Completed: Jan 31, 2026
3 conditions1 sponsor3 locations
NCT06770634
Investigation of Central Sensitization and Associated Factors in Patients With Lipedema
N/ARecruiting
50 participants
Started: Dec 6, 2024 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT06459791
Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)
NARecruiting
110 participants
Started: Dec 6, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor3 locations
NCT06819293
IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma
PHASE1Recruiting
12 participants
Started: Dec 6, 2024 · Completed: Dec 7, 2027
2 conditions1 sponsor1 location
NCT07003100
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
N/ARecruiting
100 participants
Started: Dec 6, 2024 · Completed: Oct 19, 2026
9 conditions2 sponsors10 locations
NCT06678243
"Testing the mHealth App Intervention for Nondaily Smokers SiS4"
NARecruiting
1,600 participants
Started: Dec 6, 2024 · Completed: Jul 1, 2028
1 condition3 sponsors1 location
NCT06505447
PICU-related Sleep and Circadian Dysregulation Pilot Study
NARecruiting
30 participants
Started: Dec 6, 2024 · Completed: Jan 1, 2026
4 conditions1 sponsor1 location
NCT06465316
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
26 participants
Started: Dec 6, 2024 · Completed: Sep 16, 2026
2 conditions1 sponsor9 locations
NCT06381154
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
PHASE2Recruiting
25 participants
Started: Dec 6, 2024 · Completed: Dec 6, 2029
6 conditions2 sponsors1 location
NCT06313437
Revumenib in Combination With 7+3 + Midostaurin in AML
PHASE1Recruiting
22 participants
Started: Dec 6, 2024 · Completed: Mar 2, 2027
5 conditions2 sponsors2 locations
NCT06647225
Using Artificial Intelligence to Screen for Hip Dysplasia
NARecruiting
240 participants
Started: Dec 6, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06450210
Safety for Home Administration of Microdose Psilocybin Use
PHASE1Recruiting
20 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06562283
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
NARecruiting
80 participants
Started: Dec 6, 2024 · Completed: Oct 31, 2026
3 conditions1 sponsor4 locations
NCT06579404
Closed-loop in Adults With Type 2 Diabetes
NARecruiting
224 participants
Started: Dec 6, 2024 · Completed: Jul 31, 2027
1 condition4 sponsors12 locations
NCT06519682
A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
NARecruiting
20 participants
Started: Dec 6, 2024 · Completed: Aug 31, 2029
2 conditions3 sponsors1 location
NCT06609902
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
NARecruiting
70 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2028
2 conditions1 sponsor1 location
NCT06083480
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
PHASE4Recruiting
148 participants
Started: Dec 6, 2024 · Completed: Mar 31, 2029
3 conditions2 sponsors1 location
NCT06855407
Hypertension and Cerebrovascular Hemodynamics in General Anaesthesia
NARecruiting
30 participants
Started: Dec 6, 2024 · Completed: Jun 1, 2027
4 conditions2 sponsors1 location
NCT06654596
Efficacy and Safety of Telitacicept in IgAN
NARecruiting
118 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2026
4 conditions12 sponsors1 location
NCT06507072
Adaptive Rock Climbing
NARecruiting
20 participants
Started: Dec 6, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06826339
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
PHASE4Recruiting
340 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
9 conditions2 sponsors1 location
NCT06681766
A Study to Assess Nomlabofusp in Adolescents and Children with Friedreich's Ataxia
PHASE1Recruiting
30 participants
Started: Dec 6, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06686745
Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
PHASE1Recruiting
130 participants
Started: Dec 6, 2024 · Completed: Dec 30, 2028
1 condition2 sponsors2 locations
NCT06716151
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
PHASE1Recruiting
60 participants
Started: Dec 6, 2024 · Completed: Nov 20, 2025
1 condition1 sponsor1 location
NCT06701422
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
NARecruiting
36 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor2 locations
NCT06728241
Virtual Reality and Artificial Intelligence in Treatment for Patients With Psychosis
NARecruiting
150 participants
Started: Dec 6, 2024 · Completed: Jul 31, 2028
1 condition1 sponsor2 locations
NCT06888310
Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease
NARecruiting
408 participants
Started: Dec 6, 2024 · Completed: Mar 1, 2027
2 conditions1 sponsor1 location
NCT06757569
Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden
NARecruiting
160 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06878625
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
PHASE2Recruiting
138 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06725108
Hemodynamic ABI Monitor
N/ARecruiting
50 participants
Started: Dec 6, 2024 · Completed: Dec 6, 2026
2 conditions2 sponsors1 location
NCT06773988
Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy
N/ARecruiting
17 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06856525
Dissolved Phase HXe-129 MRI: a Novel Biomarker to Quantify Pulmonary Pathology in Young Healthy E-cigarette Users
PHASE2/PHASE3Recruiting
80 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2032
1 condition3 sponsors2 locations
NCT06161285
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
N/ARecruiting
120 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors3 locations
NCT06728332
An Observational Study to Learn More About How Menopause Affects Women's Sleep and How They Are Being Treated for Sleep Problems
N/ARecruiting
1,000 participants
Started: Dec 6, 2024 · Completed: Oct 14, 2025
1 condition1 sponsor1 location
NCT05962229
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
PHASE1Recruiting
18 participants
Started: Dec 6, 2024 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06494904
Standard Versus High Dose ED-Initiated Buprenorphine Induction
PHASE3Recruiting
360 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2028
1 condition5 sponsors5 locations
NCT06983327
Brief Intervention for Chronic Pain and History of Stressful Experiences
NARecruiting
50 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06667908
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
130 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor23 locations
NCT06834932
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
PHASE2/PHASE3Recruiting
300 participants
Started: Dec 6, 2024 · Completed: Jun 18, 2027
1 condition1 sponsor40 locations
NCT06735755
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
PHASE1/PHASE2Recruiting
36 participants
Started: Dec 6, 2024 · Completed: Dec 30, 2027
1 condition1 sponsor2 locations
NCT06383247
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
NARecruiting
290 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05964140
The MANTRA Trial (MANdibular TRauma and Antibiotic Use)
PHASE3Recruiting
2,841 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor2 locations